Analysts expect over 2021 rising revenue Pfizer, relatively high dividend

Tomorrow the American Pfizer will report its past quarters results. For this year Pfizer 's (located in New York City) revenue will be around 62.99 billion USD. This is according to the average of the analysts' estimates. This is hugely more than 2020's revenue of 41.91 billion USD.

Historical revenues and results Pfizer plus estimates 2020

The analysts expect for 2021 a net profit of 19.1 billion USD. According to most of the analysts the company will have a profit per share for this book year of 3.36 USD. The price/earnings-ratio is then 11.5.

Huge dividend Pfizer

For this year the analysts expect a dividend of 1.57 USD per share. The dividend yield is then 4.06 percent. The average dividend yield of the pharmaceutical companies is a limited 1.39 percent.

Recent target prices around 39 USD

The most recent recommendations for the pharmaceutical company are from Goldman Sachs , DZ Bank and KBC Securities.

Based on the current number of outstanding shares Pfizer 's market capitalization is 213.89 billion USD. The Pfizer stock was the past 12 months quite volatile. Since last May the stock is 13 percent higher. This year the stock price moved between 30 and 43 dollar.

Historical stock prices Pfizer2007-2021

On Friday the stock closed at 38.65 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.